Han Yunkyung, Jung Hyo Won, Park Yong-Ki
Korean Medicine R&D Center, Dongguk University, Gyeongju 780-714, Republic of Korea.
Am J Chin Med. 2014;42(5):1169-82. doi: 10.1142/S0192415X14500736. Epub 2014 Aug 29.
The aim of the present study was to identify the selective therapeutic effects of Corni Fructus (Cornus officinalis Sieb. et Zucc.) on different organs in streptozotocin (STZ)-induced diabetic rats. Diabetes in rats was induced by intraperitonal injection with STZ at a dose of 30 mg/kg body weight (bw) for 3 days (once per a day). STZ-induced diabetic rats were orally administrated Corni Fructus (CF) extract at 300 mg/kg or metformin at 250 mg/kg daily for 4 weeks. Blood glucose and triglyceride (TG) in sera and urine total volume were measured. Histopathological changes of different organs, pancreas, liver, kidney, and lung tissues were observed by H&E staining. The expression of insulin and α-smooth muscle actin (α-SMA) was investigated in pancreas, and kidney by immunohistochemistry, respectively. The results revealed that CF extract significantly decreased the serum levels of blood glucose, and TG, and also urine total volume in STZ-induced diabetic rats. The histological examinations revealed amelioration of diabetes-induced pancreas injury including pathological changes of the Langerhans's islet and glomerular with their loss after the administration of CF extraction. Moreover, the administration of CF extract increased the numbers of insulin releasing beta cells in pancreas and also inhibited the expression of α-SMA in kidney of STZ-induced diabetic rats. On the other hand, CF extract showed no effect on the pathological damages of liver and lung in STZ-induced diabetic rats. These results demonstrated that CF extract may have a selective therapeutic potential through the control of hyperglycemia, and the protection of pancreas and kidney against diabetic damage.
本研究的目的是确定山茱萸(山茱萸科植物山茱萸)对链脲佐菌素(STZ)诱导的糖尿病大鼠不同器官的选择性治疗作用。通过腹腔注射30mg/kg体重(bw)的STZ,连续3天(每天一次)诱导大鼠患糖尿病。给STZ诱导的糖尿病大鼠每日口服300mg/kg的山茱萸提取物或250mg/kg的二甲双胍,持续4周。测量血清中的血糖和甘油三酯(TG)以及尿总量。通过苏木精-伊红(H&E)染色观察胰腺、肝脏、肾脏和肺组织等不同器官的组织病理学变化。分别通过免疫组织化学研究胰腺和肾脏中胰岛素和α-平滑肌肌动蛋白(α-SMA)的表达。结果显示,山茱萸提取物显著降低了STZ诱导的糖尿病大鼠的血清血糖和TG水平以及尿总量。组织学检查显示,给予山茱萸提取物后,糖尿病诱导的胰腺损伤有所改善,包括胰岛和肾小球的病理变化及其损伤减轻。此外,给予山茱萸提取物增加了胰腺中释放胰岛素的β细胞数量,并抑制了STZ诱导的糖尿病大鼠肾脏中α-SMA的表达。另一方面,山茱萸提取物对STZ诱导的糖尿病大鼠的肝脏和肺的病理损伤没有影响。这些结果表明,山茱萸提取物可能通过控制高血糖以及保护胰腺和肾脏免受糖尿病损伤而具有选择性治疗潜力。